BioLab Holdings Expands Its Workforce
In a move underscoring its commitment to innovation and community, BioLab Holdings, Inc., based in Phoenix, Arizona, has announced the hiring of 37 new professionals across various departments. This significant personnel expansion is aimed at bolstering the company’s ability to deliver high-quality wound care products and services.
Commitment to Growth
BioLab Holdings specializes in wound care solutions, leveraging human tissue allografts derived from amniotic membrane. The recent hiring spree reflects the company's strategic initiative to enhance research capacity, quality assurance, and compliance measures. President Jaime Leija emphasized this focus, stating, "We’re investing in people to empower BioLab's next chapter, enabling us to bring advanced wound-care solutions to more patients while adhering to the highest standards of regulation."
This expansion is not merely a numbers game; it represents a deliberate strategy to contribute positively to the local economy and the wider healthcare landscape. By investing in talent, BioLab aims to foster sustainable growth while improving outcomes for patients and healthcare providers.
New Team Members
Among the new hires is Chris Silvers, who has taken the helm as the Vice President of Quality Assurance. With over 25 years in the medical device and life sciences fields, Silvers brings an extensive background that includes developing robust global quality strategies, improving regulatory affairs, and navigating international audits. His addition positions BioLab to strengthen its quality assurance capabilities crucial in delivering reliable wound care products.
Chief Compliance Officer Dixon Terry, also a May recruit, holds 30 years of experience in both large and startup organizations within the biopharmaceutical and medical device sectors. His expertise includes managing compliance programs across U.S. and international markets, ensuring that BioLab meets federal and state healthcare program requirements.
The company is also welcoming Weston Quinn, a newly graduated Ph.D. in Molecular Genetics from Arizona State University, who will be focusing on advancing wound healing research. With a commitment to professional development, BioLab continues to cultivate talent that is eager to innovate within the company’s mission.
Complete List of New Hires
Quality Department:
- - Chris Silvers, VP of Quality Assurance
- - Nick Swanson, Quality Engineering Supervisor
- - Jennifer Battle, Complaint QMS Analyst
- - Brenda Sparks, Quality Auditor
- - Nancy Salas-Patton, Quality Inspector II
- - Lea Junia, Microbiology Quality Assurance Specialist
Research & Product Development:
- - Drew Norowski, Product Development Engineer
- - Savannah Redmond, Project Coordinator
- - Deanna Montrose, Chief Innovation Officer
- - Breanna Kirchhardt, Project Manager
Corporate Compliance:
- - Dixon Terry, Chief Compliance Officer
- - Kessa Chanthavongsa, Compliance Manager/Paralegal
Operations:
- - Zachry Kuhl, Operations Floater
- - Austin Feldman, Director of Supply Chain Operations
- - Minh Pham, Senior Manufacturing Engineer
- - Jesse Garcia, Senior Facilities Technician
Sales & Marketing:
- - Brennan Lagemann and Alex Albergo, Regional Sales Managers
- - Carter Righi, Product Manager
- - Collete Roth, Marketing Coordinator
Finance & Accounting:
- - Jim Doroz, Director of Financial Planning Analysis
- - Pete Wolfrom, Senior Cost Accountant
Information Technology:
- - Klint Price, Chief Technology Officer
This dynamic hiring strategy positions BioLab Holdings as a formidable player in the wound care industry, dedicated not just to growth but to improving the lives of those it serves. The company's innovative approach, underpinned by its expanding workforce, promises to leave a lasting impact on healthcare delivery and community support.
For more information on BioLab’s product offerings, including their range of amniotic membrane allografts, visit
biolabholdings.com.